Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kumar Prabhash

Showing results (291-300 of 469) with videos related to

Pageof 47
Sort By:
JTO Clinical and Research Reports|January 19, 2023
Clinical Profile, Practice Pattern, and Outcomes With First-Line Therapy in ALK-Positive Lung Cancer: Real-World Data From Resource-Constrained SettingsAkhil Kapoor, Vanita Noronha, Vijay Patil, et al.
Nuclear Medicine Communications|February 9, 2021
Improving accuracy of 18F-fluorodeoxyglucose PET computed tomography to diagnose nodal involvement in non-small cell lung cancer: utility of using various predictive modelsBoon Mathew, Nilendu C Purandare, C S Pramesh, et al.
British Journal of Cancer|February 10, 2022
Prognostic and predictive roles of cancer stem cell markers in head and neck squamous cell carcinoma patients receiving chemoradiotherapy with or without nimotuzumabUsha Patel, Sadhana Kannan, Swapnil U Rane, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 1, 2023
Diagnostic Performance of Response Assessment FDG-PET/CECT in HNSCC Treated With Definitive Radio(chemo)therapy Using NI-RADSSonz Paul, Tejpal Gupta, Nilendu Purandare, et al.
Indian Journal of Cancer|January 14, 2020
Stereotactic body radiation therapy for medically inoperable early-stage lung cancer: Tata Memorial Hospital perspective and practice recommendationsJai Prakash Agarwal, Avinash Pilar, Naveen Mummudi, et al.
Oral Oncology|June 10, 2018
Depth of invasion, size and number of metastatic nodes predicts extracapsular spread in early oral cancers with occult metastasesManish D Mair, Rathan Shetty, Deepa Nair, et al.
South Asian Journal of Cancer|December 31, 2025
Safety and Efficacy of Alectinib in the First Line for ALK-Mutated Lung Cancer: A Real-World Data from IndiaAjaykumar Singh, Vanita Noronha, Vijay Patil, et al.
JCO Global Oncology|July 17, 2025
Comprehensive Genomic Profiling of Anaplastic Thyroid Cancer Identifies Alterations in <i>THRA</i>, a Potential Modifier of Cellular PlasticityVaishakhi Trivedi, Vanita Noronha, Munita Bal, et al.
Nuclear Medicine Communications|April 30, 2024
Can 18 F FDG PET/CT metabolic parameters be used to noninvasively differentiate between different histopathological subtypes and Fuhrman grades of renal cell cancer?Yash Jain, Archi Agrawal, Amit Joshi, et al.
Journal of Global Oncology|August 24, 2017
Survey of Implementation of Antiemetic Prescription Standards in Indian Oncology Practices and Its Adherence to the American Society of Clinical Oncology Antiemetic Clinical GuidelineVijay Patil, Vanita Noronha, Amit Joshi, et al.
Pageof 47

Showing results (291-300 of 469) with videos related to

Sort By:
Pageof 47
JTO Clinical and Research Reports|January 19, 2023
Clinical Profile, Practice Pattern, and Outcomes With First-Line Therapy in ALK-Positive Lung Cancer: Real-World Data From Resource-Constrained SettingsAkhil Kapoor, Vanita Noronha, Vijay Patil, et al.
Nuclear Medicine Communications|February 9, 2021
Improving accuracy of 18F-fluorodeoxyglucose PET computed tomography to diagnose nodal involvement in non-small cell lung cancer: utility of using various predictive modelsBoon Mathew, Nilendu C Purandare, C S Pramesh, et al.
British Journal of Cancer|February 10, 2022
Prognostic and predictive roles of cancer stem cell markers in head and neck squamous cell carcinoma patients receiving chemoradiotherapy with or without nimotuzumabUsha Patel, Sadhana Kannan, Swapnil U Rane, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 1, 2023
Diagnostic Performance of Response Assessment FDG-PET/CECT in HNSCC Treated With Definitive Radio(chemo)therapy Using NI-RADSSonz Paul, Tejpal Gupta, Nilendu Purandare, et al.
Indian Journal of Cancer|January 14, 2020
Stereotactic body radiation therapy for medically inoperable early-stage lung cancer: Tata Memorial Hospital perspective and practice recommendationsJai Prakash Agarwal, Avinash Pilar, Naveen Mummudi, et al.
Oral Oncology|June 10, 2018
Depth of invasion, size and number of metastatic nodes predicts extracapsular spread in early oral cancers with occult metastasesManish D Mair, Rathan Shetty, Deepa Nair, et al.
South Asian Journal of Cancer|December 31, 2025
Safety and Efficacy of Alectinib in the First Line for ALK-Mutated Lung Cancer: A Real-World Data from IndiaAjaykumar Singh, Vanita Noronha, Vijay Patil, et al.
JCO Global Oncology|July 17, 2025
Comprehensive Genomic Profiling of Anaplastic Thyroid Cancer Identifies Alterations in <i>THRA</i>, a Potential Modifier of Cellular PlasticityVaishakhi Trivedi, Vanita Noronha, Munita Bal, et al.
Nuclear Medicine Communications|April 30, 2024
Can 18 F FDG PET/CT metabolic parameters be used to noninvasively differentiate between different histopathological subtypes and Fuhrman grades of renal cell cancer?Yash Jain, Archi Agrawal, Amit Joshi, et al.
Journal of Global Oncology|August 24, 2017
Survey of Implementation of Antiemetic Prescription Standards in Indian Oncology Practices and Its Adherence to the American Society of Clinical Oncology Antiemetic Clinical GuidelineVijay Patil, Vanita Noronha, Amit Joshi, et al.
Pageof 47